National Study Shows: AREDS Formula Reduces Risk of AMD
The National Eye Institute's "Age-Related Eye Disease Study" (AREDS) proved that high levels of antioxidants and zinc reduced the risk of AMD by 25% for those at high risk.
Viteyes® AREDS formula eye vitamins contain this recommended dosage clinically proven to delay the progression of AMD.
Why Are Viteyes AREDS Formulas the Wise Choice for Your Eye Health?
Less expensive than other leading brands
Clinically proven formula
Just 2 capsules daily
Easy-to-swallow
Convenient, Free Home Delivery
(orders over $35 in the US)
Highly soluble
Made in the USA
Remember to take your pills! Try our new 7-day pill holder! Only $4.95. Click here!
In October 2001, the National Eye Institute (NEI) one of the Federal Government's National Institutes of Health (NIH) completed a large ten-year study, the Age-Related Eye Disease Study (AREDS). AREDS proved that the formula in Viteyes macular degeneration vitamins can slow the progression of Macular Degeneration by 25% in people at risk of developing advanced stages of the disease. Viteyes supplies the AREDS recommended formula in only TWO daily highly soluble, easy-to-swallow capsules.
Age-related macular degeneration (AMD) is the leading cause of blindness in people over the age of 55 affecting over 6 million people in the United States. AMD is the degeneration of the central part of the retina called the macula. The macula is the part of the retina that is responsible for straight-ahead vision. People with AMD should speak with their doctor about macular degeneration vitamins featuring the AREDS formula.
